A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...

The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...

Need a meaty, cloddish, yet affable Everyman who can act? Paul Walter Hauser knows how to own the body type.

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

Eli Lilly & Company (NYSE: LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

Restaurants across the U.S. are introducing “Ozempic menus” with smaller, protein-rich portions to cater to millions using ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Novo Nordisk A/S (NYSE: NVO) has reported that it retains about sixty percent of the list price of Ozempic and Wegovy, its ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...